#SNO2024: @washumedicine's Dr. Anastasaki (@Corina_Anast), from the @GutmannLab, shared details about her invaluable time at @NeuroOnc, including a preview of her presentation tomorrow entitled, 'Neurotransmitter dependency underlies tumor growth in humanized pediatric low-grade glioma models.'
Be sure to attend Sunday at 9:40 a.m. in General Assembly Room A. @WashuMedBTC
A Friday of celebration! Happiest of birthdays to our super students Megan and Talia @eligatort and of course the captain of this ship @GutmannLab 🎉🎉🎂here’s to celebrating all of you!!
We are pleased to welcome Yunshuo “Caroline” Tang, MD, PhD, to our team of Neuro-Ophthalmology Faculty.
Dr. Tang recently completed her neuro-ophthalmology fellowship with us, and we are excited to add her to our team physicians.
@WashUNeurology
https://t.co/DtsNMvZEdW
Neurofibromatosis (#NF1) is a neurogenetic syndrome associated with learning impairments and a predisposition for glial tumors. We find that NF1 mutation causes an intrinsic deficit in oligodendrocyte precursor cell (OPC) differentiation. A thread 🧵 1/
https://t.co/kJP9eNAKpF
Join @WashUGenetics today @ noon CST in Connor Auditorium when Dr. David Gutmann @GutmannLab, presents (in-person only) “Neuronal regulation of nervous system tumor formation and progression”, hosted by Dr. Guoyan Zhao @gzhao11
New work from the @GutmannLab at @WUSTL demonstrates that NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine #OpticGlioma. 🐭
Learn more: https://t.co/I3wirZe9BA
@Corina_Anast has done it again. Cancer neuroscience rules and neuronal hyperactivity can be therapeutically targeted to treat brain tumors in children with #NF1
https://t.co/t8K5O6N3iv
It was "roast" day in the @GutmannLab, celebrating the major contributions of @Corina_Anast and @jit_chatterjee1 over these many years. We are so fortunate to have such amazing lab leaders!